One World Products (OWPC) Total Non-Current Liabilities (2018 - 2025)
One World Products (OWPC) recorded quarterly Total Non-Current Liabilities of $2.1 million in Q3 2025, up 25.09% quarter-over-quarter from $1.7 million in Q2 2025, and up 14.08% on a YoY basis from $1.9 million in Q3 2024.
One World Products (OWPC) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
One World Products' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $2.1 million for Q3 2025.
- In Q3 2025, Total Non-Current Liabilities rose 14.08% year-over-year to $2.1 million; the TTM figure through Sep 2025 stood at $2.1 million (up 14.08% YoY), while the FY2024 annual figure was $1.5 million, up 143.21% from the prior year.
- Total Non-Current Liabilities was $2.1 million for Q3 2025 at One World Products, up from $1.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $6.8 million in Q3 2023 to a low of -$3.5 million in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $2.6 million across 5 years, with a median of $2.1 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 268.59% in 2022, then plunged 249.56% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $2.4 million in 2021, then dropped by 2.36% to $2.3 million in 2022, then slumped by 249.56% to -$3.5 million in 2023, then surged by 143.21% to $1.5 million in 2024, then jumped by 42.19% to $2.1 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $2.1 million (Q3 2025), $1.7 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | One World Products | - | - | 48,591.00 | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Dec 31, 2023 | -3.48 Mn |
| Sep 30, 2023 | 6.78 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | 6.24 Mn |
| Dec 31, 2022 | 2.32 Mn |
| Sep 30, 2022 | 3.69 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 5.33 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 1.75 Mn |
| Mar 31, 2021 | 2.12 Mn |
| Dec 31, 2020 | 2.19 Mn |